Jørgensen O D, Kronborg O, Fenger C
Dept. of Surgical Gastroenterology, Odense University Hospital, Denmark.
Scand J Gastroenterol. 1993 Oct;28(10):869-74. doi: 10.3109/00365529309103127.
The results of a prospective randomized study of 1056 patients with colorectal adenomas are presented. After initial polypectomy from 1978 to 1992, patients were allocated at random to different follow-up intervals varying from 6 to 48 months, except 53 patients who were allocated to intervals of 6 months. The examinations were mainly done by colonoscopy. Ten patients developed colorectal carcinoma, a number similar to that expected (7.96), when compared with a sex- and age-matched normal Danish population. The expected number of carcinomas was also calculated from adenoma to carcinoma conversion rates estimated in other studies and compared with that observed. If all carcinomas develop in large (> or = 10 mm) adenomas or adenomas with severe dysplasia, the expected number of carcinomas would have been 62 and 110, respectively, indicating a significant reduction of carcinomas in the present study. One patient died of colorectal carcinoma, which is significantly lower than the number expected (7.58). Two patients died of complications from therapeutic and diagnostic colonoscopy--that is, 2 deaths in 3959 colonoscopies. In conclusion, the follow-up strategy has resulted in a mortality from colorectal carcinoma which is reduced when compared with the normal population, in spite of an apparently similar incidence of carcinoma. However, previous suggested adenoma-carcinoma conversion rates indicate that a major reduction of incidence actually has taken place.
本文呈现了一项针对1056例大肠腺瘤患者的前瞻性随机研究结果。1978年至1992年期间,患者在初次息肉切除术后被随机分配至不同的随访间隔,从6个月至48个月不等,但有53例患者被分配至6个月的随访间隔。检查主要通过结肠镜进行。10例患者发生了结直肠癌,与性别和年龄匹配的丹麦正常人群相比,这一数字与预期数量(7.96)相近。预期的癌症数量还根据其他研究估计的腺瘤到癌的转化率进行计算,并与观察到的数量进行比较。如果所有癌症都发生在大(≥10毫米)腺瘤或伴有重度发育异常的腺瘤中,预期的癌症数量分别为62例和110例,这表明本研究中癌症数量显著减少。1例患者死于结直肠癌,这明显低于预期数量(7.58)。2例患者死于治疗性和诊断性结肠镜检查的并发症——即在3959次结肠镜检查中有2例死亡。总之,尽管癌症发病率明显相似,但与正常人群相比,这种随访策略导致结直肠癌死亡率降低。然而,先前提出的腺瘤到癌的转化率表明实际上发病率已大幅降低。